S-Class
2026-07-29 19:21:24
Biogen beats top-line and bottom-line estimates; updates FY26 outlook
S-Class
2026-07-14 11:46:06
FDA approves subcutaneous Leqembi for Alzheimer’s initiation
S-Class
2026-07-14 07:58:45
Biogen nabs approval of subcutaneous version of Leqembi for initiation dose
S-Class
2026-06-28 16:35:34
Biogen to acquire Apellis Pharmaceuticals stock for $5.6 billion
S-Class
2026-06-28 16:07:13
Biogen Snaps Up Apellis Pharma For $5.6 Billion, But Biogen Dives As Apellis Soars
1 / 2